GRCL

Gracell Biotechnologies Inc. American Depositary Shares
GRCL

Overview Fund Activity
Delisted

GRCL was delisted on the 21st of February, 2024.

Back to rankings

33 hedge funds and large institutions have $70M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$4.51M
2
EC
2
EcoR1 Capital
California
$7.69M
3
SSA
3
Schonfeld Strategic Advisors
New York
$862K
4
CCMU
4
Cheyne Capital Management (UK)
United Kingdom
$226K
5
Barclays
5
Barclays
United Kingdom
$198K

Top Sellers

1
FLSM
1
Frazier Life Sciences Management
California
$0
2
Morgan Stanley
2
Morgan Stanley
New York
$51.3K
3
Invesco
3
Invesco
Georgia
$0
4
CII
4
Capital International Inc
California
$6.77M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$5K -$3.08K -1,249 -38%
National Bank of Canada
27
National Bank of Canada
Quebec, Canada
$2.79K -$954 -420 -25%
Citigroup
28
Citigroup
New York
$1.77K +$122 +53 +7%
CUAMC
29
China Universal Asset Management Company
China
$1.56K +$124 +54 +9%
EBA
30
Eagle Bay Advisors
New York
$483 – – –
SOW
31
State of Wyoming
Wyoming
$426 +$362 +157 +561%
FLSM
32
Frazier Life Sciences Management
California
– -$9.31M -2,890,102 Closed
Invesco
33
Invesco
Georgia
– -$302K -93,907 Closed
Balyasny Asset Management
34
Balyasny Asset Management
Illinois
– -$79K -24,646 Closed
1
2